NCT04603963

Brief Summary

COVID 19 has become a pandemic and has led to high demand on healthcare systems. It can cause a severe acute respiratory syndrome (SARS CoV-2) which leads to a long hospital stay, developing important functional damage and making hospital discharge difficult. Elderly, obese and people with chronic diseases are more susceptible to contracting the disease, this profile of patients already has a predisposition for respiratory muscle weakness and in this context, after clinical stability, it is still necessary in a hospital environment to approach respiratory and motor physiotherapy. to optimize the recovery of these patients. Objective: Improved breathing, functionality, exercise capacity and muscle strength in non-critical patients. Method: Prospective randomized clinical study where one group received motor and respiratory physiotherapy and the other group performed the same therapy associated with inspiratory muscle training. Results: The findings will be compared before and after the approach and will be presented in graphs and tables. Statistical tests will be used considering a significance level of 5%.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2020

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

October 25, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 27, 2020

Completed
Last Updated

October 28, 2020

Status Verified

October 1, 2020

Enrollment Period

4 months

First QC Date

October 25, 2020

Last Update Submit

October 26, 2020

Conditions

Keywords

physiotherapyexercisesrespiratory muscle training

Outcome Measures

Primary Outcomes (1)

  • impact on functionality

    respiratory muscle training appears to impact functionality

    14 days

Study Arms (2)

group control

NO INTERVENTION

alternate exercises: in one day breathing exercises, active or with a load of large muscle groups (according to tolerance) with a maximum limit of 2 kg, sedation out of bed, walking. On another day aerobic exercise with cycle ergometer limited to 30 minutes.

intervention group

EXPERIMENTAL

He received the same intervention as the control group, associating respiratory muscle training 1 time a day with power breathe 3 series of 10 repetitions (started with 30% of the Pimax value) with readjusted load every 7 days.

Device: power breathe

Interventions

respiratory muscle training 1 time a day with power breathe 3 sets of 10 repetitions

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients diagnosed with COVID-19 through PCR aged over 18 years admitted to non-critical units.

You may not qualify if:

  • patients with changes in the level of consciousness and non-transient understanding, exclusive palliative care without prognosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Municipal Hospital Vila Santa Catarina

São Paulo, 04377035, Brazil

Location

MeSH Terms

Conditions

COVID-19Respiration DisordersMotor Activity

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Stratified randomization was performed in which the impaired chest tomography (absent, less than 50% or greater than 50%)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Only patients with respiratory muscle weakness that were considered as the maximum inspiratory pressure value (less than or equal to 60% of the predicted value) entered for randomization. Stratified randomization was performed in which the impaired chest tomography (absent, less than 50% or greater than 50%) was taken into account to be randomly allocated to the groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
physiotherapist

Study Record Dates

First Submitted

October 25, 2020

First Posted

October 27, 2020

Study Start

June 1, 2020

Primary Completion

October 10, 2020

Study Completion

October 23, 2020

Last Updated

October 28, 2020

Record last verified: 2020-10

Locations